Koblan, Luke W. https://orcid.org/0000-0003-2814-4412
Erdos, Michael R. https://orcid.org/0000-0002-6603-1833
Wilson, Christopher https://orcid.org/0000-0002-8012-2440
Cabral, Wayne A. https://orcid.org/0000-0002-0563-5289
Levy, Jonathan M. https://orcid.org/0000-0002-8061-7953
Xiong, Zheng-Mei
Tavarez, Urraca L. https://orcid.org/0000-0002-2577-5377
Davison, Lindsay M.
Gete, Yantenew G.
Mao, Xiaojing
Newby, Gregory A.
Doherty, Sean P.
Narisu, Narisu https://orcid.org/0000-0002-8483-1156
Sheng, Quanhu
Krilow, Chad
Lin, Charles Y. https://orcid.org/0000-0002-9155-090X
Gordon, Leslie B.
Cao, Kan https://orcid.org/0000-0002-5806-2939
Collins, Francis S. https://orcid.org/0000-0002-1023-7410
Brown, Jonathan D. https://orcid.org/0000-0002-0359-6167
Liu, David R. https://orcid.org/0000-0002-9943-7557
Article History
Received: 9 June 2020
Accepted: 30 November 2020
First Online: 6 January 2021
Competing interests
: D.R.L. is a co-founder of Beam Therapeutics, Prime Medicine, Pairwise Plants and Editas Medicine, companies that use genome editing. The remaining authors declare no competing interests.